InvestorsHub Logo

eightisenough

10/09/20 3:28 AM

#304010 RE: alm2 #304007

alm-respondent's CANNOT answer w/o court permission. Silence means=0

You are way ahead of yourself w/ criminal investigations. slow down.

8

Biobillionair

10/09/20 7:06 AM

#304024 RE: alm2 #304007

Good post alm2. How does Hikma respond? Will Hikma really have time to respond or will they think, ‘if we get caught defrauding the US court in a paragraph 4 ANDA patent suit litigation there’s a good chance we get banned from doing business in the US all together.‘ What’s stopping me from bringing the FDA into this? Nothing! FDA controls rules regarding paragraph 4’s and this defrauding of the court is loosely covered...might need to tighten up these rules some....

Does anyone know how to get ahold of Janet Woodcock?

BB

rafunrafun

10/09/20 7:14 AM

#304027 RE: alm2 #304007

Has anyone notified Dr Heinecke? Is that a good idea for any of us to do so?

'Hey doc, you've just been accused of defrauding the court. Good luck, sucka'

marjac

10/09/20 3:03 PM

#304133 RE: alm2 #304007

Fantastic write-up and analysis alm. I did not know that you were an attorney in the UK. That is awesome. If I ever have a referral needing UK counsel, I will most certainly contact you.

I agree that it will be interesting to see how this all unfolds. As to the Mori/Bhatt, as I explained yesterday, I was going there, but then Markman stated in no uncertain terms that advancing such a position would ensure en banc rejection. I made the decision on the fly, several hours before filing, to pivot exclusively to the arguments that we made, as I feel they are strong. With the long en banc odds, the prudent practice is to increase the odds of being heard, rather than decrease them.